Gilead Sciences 4Q profit rises on HIV drug sales - CBS News - RTT NewsGilead Sciences 4Q profit rises on HIV drug salesCBS NewsGilead Sciences Inc.'s profit grew 6 percent in the fourth quarter on greater sales of its HIV drugs including Atripla. Gilead said Thursday that its profit rose to $665.1 million, or 87 cents per share, from $629.4 million, or 76 cents per share, ...Gilead fourth-quarter profit rises 5.7%MarketWatchGilead 4Q Profit Falls Short of Street ViewFox BusinessGilead Sciences' Earnings, Outlook Miss EstimatesInvestor's Business DailyNASDAQ -EON: Enhanced Online News (press release)all 28 news articles » [Google HIV NEWS]